CClinicalTrials.gg
CompletedNCT03444090Updated May 9, 2019Results posted

Impacts of Inspection During Instrument Insertion on Colonoscopy Quality

An interventional study of Colon polypectomy in Colon Polyp and Colon Adenoma, sponsored by Evergreen General Hospital, Taiwan. Completed at 1 site in Taiwan. Open to participants aged 45 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-05-09.

Sponsored by Evergreen General Hospital, Taiwan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
428
Allocation
Randomized
Ages
45 Years and older
Sex
All
01

Study summary

Small colon polyps which are found during colonoscopy insertion are sometimes difficult to find during withdrawal and thus missed. The investigators aim to evaluate the differences of colon polyp/adenoma detection rates of patients undergoing additional inspection and polypectomy during insertion as compared to the patients undergoing traditional practice of careful inspection and polypectomy performed entirely during withdrawal of colonoscopy.

Read the detailed description

Participants will be randomly assigned by a research assistant, by using a computer-generated randomization sequence to undergo colonoscopy with either inspection and polypectomy during both insertion and withdrawal of colonoscope (study group) or inspection and polypecotmy entirely during withdrawal of colonoscope (control group). Randomization will be done via concealed allocation with a sealed envelope that designate study group or control group.

Colonoscopies will be performed by two experienced investigators by using a standard colonoscopy (CF-Q260AI or CF-Q260AL; Olympus Medical Systems Corp., Tokyo, Japan). All procedures are performed under moderate conscious sedation with fentanyl (United Biomedical, Taipei, Taiwan) and midazolam (Dormicum; Roche Pharmaceuticals, Basel, Switzerland) according to the current guidelines. Carbon dioxide insufflation is used for all endoscopic procedures. All participants receive 3-L polyethylene glycol (PEG; Klean-Prep, Helsinn Birex Pharmaceuticals Ltd., Dublin, Ireland) for bowel preparation. A split-dose of the PEG preparation is provided. The level of colon cleansing is prospectively evaluated with the Boston Bowel Preparation Scale score.

For participants assigned into the study group, the colonic lumen is washed with saline and the fluid and debris are suctioned as the instrument is slowly inserted from rectum to cecum. Deliberate and systematic inspection of the colonic mucosa is performed with adequate luminal insufflations during both the insertion and withdrawal phases. Polyp size is determined by comparison with open colonoscopic biopsy forceps pushed against the polyp or, in some cases of pedunculated polyp by direct measurement after retrieval. Polyps with size \<10mm are removed as they are identified on insertion and withdrawal. Polyps with size ≥10mm are removed only during withdrawal.

For participants assigned into the control group, deliberate mucosal inspection and polyp removal are performed exclusively on instrument withdrawal. During insertion, minimal mucosal inspection and insufflation are applied to efficiently advance the instrument into cecum. If a polyp is found during insertion, investigators are instructed to make a mental note of it and find it during withdrawal for polypectomy.

02

Conditions studied

  • Colon Polyp
  • Colon Adenoma

Browse trials for

03

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 45 years or older.
  • Agree to participate the study and provide a written informed consent

Exclusion criteria

Exclusion Criteria:

  • Previous surgical resection of the colon or rectum
  • Inflammatory bowel disease
  • Polyposis syndrome
  • Previously incomplete colonoscopy
  • Obstructive lesions of colon
  • Inadequate bowel preparation, defined as Boston Bowel Preparation Scale score of 0 or 1 in any colon segment
  • Gastrointestinal bleeding
  • Allergy to fentanyl or midazolam
  • American Society of Anesthesiology classification of physical status 3 or higher
  • Mental retardation
  • Pregnancy
  • Refusal to provide a written informed consent
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
428 participants (actual)

Study arms

  • Experimental
    Insertion/withdrawal colon polypectomy

    For participants assigned in the experimental group, the colon is washed and the debris is suctioned as the colonoscopy is slowly inserted from rectum to cecum. Deliberate and systematic inspection of the mucosa is performed with adequate insufflation during both insertion and withdrawal phases.Colon polypectomy for polyp size \<10 mm will be performed when they are identified during insertion and withdrawal of the colonoscope. Colon polypectomy for polyp size \>10 mm will be performed only during withdrawal of the scope.

    Procedure: Colon polypectomy

  • Active comparator
    Withdrawal colon polypectomy

    For participants assigned in the control group, deliberate mucosa inspection and colon polypectomy will be performed exclusively on colonoscopy withdrawal.During insertion, minimal mucosal inspection and insufflation are applied to efficiently advance the instrument into cecum.

    Procedure: Colon polypectomy

Interventions

  • ProcedureColon polypectomy

    For participants assigned into the experimental group, colon lumen is washed and the debris is suctioned as the colonoscopy is slowly inserted from rectum to cecum. Deliberate and systematic inspection of the mucosa is performed with adequate insufflation during both the insertion and withdrawal phases. Colon polyps with size \<10 mm are removed as they are identified on insertion and withdrawal. Polyps with size \>10 mm are removed only during withdrawal. For participants assigned into the control group, deliberate inspection and polyp removal are performed exclusively on colonoscopy withdrawal.During insertion, minimal mucosal inspection and insufflation are applied to efficiently advance the instrument into cecum.

05

What researchers measure

Primary outcomes

  1. Percentage of Participants With Detection of at Least One Adenoma Per Procedure

    Colon adenoma detection rate is defined as the proportion of colonoscopies where at least one adenoma is found.

    Time frame: During procedure, approximately one hour

Secondary outcomes

  1. Mean Colon Adenoma Per Colonoscopy

    Mean colon adenoma per procedure is defined as the total number of adenomas detected divided by the number of colonoscopies.

    Time frame: During procedure, approximately one hour

06

Results

Posted May 9, 2019

Participant flow

Participant flow — Overall Study
MilestoneInsertion/Withdrawal Colon PolypectomyWithdrawal Colon Polypectomy
Started214214
Completed211210
Not completed34

Outcome measures

PrimaryPercentage of Participants With Detection of at Least One Adenoma Per Procedure

Colon adenoma detection rate is defined as the proportion of colonoscopies where at least one adenoma is found.

Time frame:
During procedure, approximately one hour
Reported as:
Mean · percentage of participants
Percentage of Participants With Detection of at Least One Adenoma Per Procedure
percentage of participantsInsertion/Withdrawal Colon PolypectomyWithdrawal Colon Polypectomy
Percentage of Participants With Detection of at Least One Adenoma Per Procedure63.7 (56.6 to 70.0)68.1 (61.3 to 74.3)
SecondaryMean Colon Adenoma Per Colonoscopy

Mean colon adenoma per procedure is defined as the total number of adenomas detected divided by the number of colonoscopies.

Time frame:
During procedure, approximately one hour
Reported as:
Mean · adenomas/colonoscopy
Mean Colon Adenoma Per Colonoscopy
adenomas/colonoscopyInsertion/Withdrawal Colon PolypectomyWithdrawal Colon Polypectomy
Mean Colon Adenoma Per Colonoscopy1.6 ± 2.01.9 ± 2.4

Adverse events

Collected over one month. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Insertion/Withdrawal Colon Polypectomy0/211 (0%)0/211 (0%)0/211 (0%)
Withdrawal Colon Polypectomy0/210 (0%)0/210 (0%)0/210 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Insertion/Withdrawal Colon PolypectomyWithdrawal Colon PolypectomyTotal
Mean57.6 ± 8.558.2 ± 8.557.9 ± 8.5
Sex: Female, Male
Sex: Female, Male(Participants)Insertion/Withdrawal Colon PolypectomyWithdrawal Colon PolypectomyTotal
Female112111223
Male9999198
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Insertion/Withdrawal Colon PolypectomyWithdrawal Colon PolypectomyTotal
American Indian or Alaska Native000
Asian211210421
Native Hawaiian or Other Pacific Islander000
Black or African American000
White000
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Insertion/Withdrawal Colon PolypectomyWithdrawal Colon PolypectomyTotal
Taiwan211210421
07

Study locations

1 site
  • Evergreen General Hospital
    Taoyuan, 320, Taiwan
08

References and documents

Publications

  • Cheng CL, Kuo YL, Liu NJ, Tang JH, Fan JW, Lin CH, Tsui YN, Lee BP, Hung HL. Comparison of polyp detection during both insertion and withdrawal versus only withdrawal of colonoscopy: A prospective randomized trial. J Gastroenterol Hepatol. 2019 Aug;34(8):1377-1383. doi: 10.1111/jgh.14613. Epub 2019 Feb 27. PubMed 30675926 ↗

Study documents

  • Protocol and statistical analysis plan · Aug 7, 2017

Documents are hosted by the registry — open the source record to download them.

09

Registry details

Key details

Study ID
NCT03444090
Lead sponsor
Evergreen General Hospital, Taiwan
Responsible party
Chi-Liang Cheng (Director of Gastroenterology, Evergreen General Hospital, Taiwan) — Principal investigator
First posted
Feb 23, 2018
Start date
Oct 2, 2017
Primary completion
Jun 30, 2018
Completion
Jun 30, 2018
Results posted
May 9, 2019
Last update
May 9, 2019

Study contacts

Chiliang Cheng
principal investigator · Evergreen General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion